The rate of positive tests for a virus that swept hospitals in China is on the rise in the England, according to official figures. Latest UK Health Security Agency data show one in 20 (5 per cent) of ...

A typically lesser known virus is looking to make its mark this winter – the human metapneumovirus (HMPV). The latest figures by the UK Health and Security Agency (UKHSA) shows 5 per cent of people of ...

As winter settles over Australia, it's not just the drop in temperature we notice—there's also a sharp rise in respiratory illnesses. Most of us are familiar with the usual winter players such as ...

While headlines have described it as a "mystery illness," health experts have known about the HMPV for decades. The respiratory virus can be a serious health threat, particularly for children and ...

Among hospitalized children and teens, respiratory syncytial virus (RSV) mostly affects younger, otherwise healthy infants, while the lesser-known human metapneumovirus (HMPV) tends to affect older ...

Sanofi is shelling out $1.15 billion to acquire Vicebio, a startup with a pipeline of respiratory vaccine candidates and a platform technology that will support the pharmaceutical giant’s ambitions to ...

Lara Herrero receives funding from the National Health and Medical Research Council. As winter settles over Australia, it’s not just the drop in temperature we notice – there’s also a sharp rise in ...